Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -160.05% is 32% below its 5-year average of -120.96%, around the middle of its 5-year range (-311.44%–-37.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 91.41% below its 12-month average of -83.61%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -160.05%.
RETURN ON EQUITY (ROE)
-160.05%
RETURN ON EQUITY (ROE) AVG TTM
-83.61%
RETURN ON EQUITY (ROE) AVG 3Y
-139.81%
RETURN ON EQUITY (ROE) AVG 5Y
-120.96%
RETURN ON EQUITY (ROE) AVG 10Y
-95.19%
RETURN ON EQUITY (ROE) AVG 15Y
-105.76%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-91.41%
CURRENT VS 3Y AVG
-14.47%
CURRENT VS 5Y AVG
-32.31%
CURRENT VS 10Y AVG
-68.14%
CURRENT VS 15Y AVG
-51.33%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.21%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
-298.03%
vs the sector median at left
Edesa Biotech, Inc.
Market Cap
$36.71M
Return on Equity (ROE)
-160.05%
TTM Avg
-83.61%
3Y Avg
-139.81%
5Y Avg
-120.96%
Market Cap
$36.80M
Return on Equity (ROE)
-476.77%
TTM Avg
-979.99%
3Y Avg
-646.46%
5Y Avg
-421.61%
Market Cap
$35.76M
Return on Equity (ROE)
-161.63%
TTM Avg
-60.21%
3Y Avg
-26.37%
5Y Avg
-20.13%
Market Cap
$36.63M
Return on Equity (ROE)
-819.34%
TTM Avg
-116.46%
3Y Avg
-74.90%
5Y Avg
-96.78%
Market Cap
$37.73M
Return on Equity (ROE)
-28.65%
TTM Avg
-189.41%
3Y Avg
-194.44%
5Y Avg
-158.64%
Market Cap
$34.97M
Return on Equity (ROE)
-154.06%
TTM Avg
-1.75%
3Y Avg
68.54%
5Y Avg
60.27%
Market Cap
$34.73M
Return on Equity (ROE)
329.02%
TTM Avg
154.76%
3Y Avg
265.18%
5Y Avg
128.71%
Market Cap
$34.50M
Return on Equity (ROE)
-44.50%
TTM Avg
-16.33%
3Y Avg
-36.34%
5Y Avg
-33.52%
Market Cap
$34.46M
Return on Equity (ROE)
-117.97%
TTM Avg
-59.96%
3Y Avg
-42.92%
5Y Avg
-31.82%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $36.71M | -160.05% | -83.61% | -139.81% | -120.96% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.80M | -476.77% | -979.99% | -646.46% | -421.61% |
| DocGo Inc. (DCGO)vs › | $35.76M | -161.63% | -60.21% | -26.37% | -20.13% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | -819.34% | -116.46% | -74.90% | -96.78% |
| Incannex Healthcare Limited (IXHL)vs › | $37.73M | -28.65% | -189.41% | -194.44% | -158.64% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -154.06% | -1.75% | 68.54% | 60.27% |
| Elutia Inc (ELUT)vs › | $34.73M | 329.02% | 154.76% | 265.18% | 128.71% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | -44.50% | -16.33% | -36.34% | -33.52% |
| Accuray Incorporated (ARAY)vs › | $34.46M | -117.97% | -59.96% | -42.92% | -31.82% |
| Harvard Bioscience, Inc. (HBIO)vs › | $39.15M | -140.36% | -216.21% | -112.57% | -76.80% |
ROE
-160.0%
ROA
-110.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -160.05% |
| 2026-03-31 | -102.42% |
| 2025-12-31 | -56.01% |
| 2025-09-30 | -57.71% |
| 2025-06-30 | -41.88% |
| 2025-03-31 | -37.57% |
| 2024-12-31 | -269.83% |
| 2024-09-30 | -311.44% |
| 2024-06-30 | -241.65% |
| 2024-03-31 | -167.54% |
| 2023-12-31 | -132.05% |
| 2023-09-30 | -118.81% |
| 2023-06-30 | -120.60% |
| 2023-03-31 | -147.45% |
| 2022-12-31 | -150.92% |
| 2022-09-30 | -186.86% |
| 2022-06-30 | -155.62% |
| 2022-03-31 | -102.17% |
| 2021-12-31 | -142.99% |
| 2021-09-30 | -102.18% |
| 2021-06-30 | -73.85% |
| 2021-03-31 | -45.03% |
| 2020-12-31 | -100.28% |
| 2020-09-30 | -95.97% |
| 2020-06-30 | -67.99% |
| 2020-03-31 | -69.71% |
| 2019-12-31 | -118.07% |
| 2019-09-30 | -101.03% |
| 2019-06-30 | -88.29% |
| 2019-03-31 | -64.67% |
| 2018-12-31 | -50.91% |
| 2018-09-30 | -44.65% |
| 2018-06-30 | -41.42% |
| 2018-03-31 | -109.59% |
| 2017-12-31 | -82.17% |
| 2017-09-30 | -67.99% |
| 2017-06-30 | -59.92% |
| 2017-03-31 | -52.35% |
| 2016-12-31 | -44.93% |
| 2016-09-30 | -40.82% |
| 2016-06-30 | -68.17% |
| 2016-03-31 | -40.44% |
| 2015-12-31 | -32.49% |
| 2015-09-30 | -35.51% |
| 2014-08-31 | -109.60% |
| 2014-05-31 | -117.54% |
| 2014-02-28 | -176.27% |
| 2013-11-30 | -232.00% |
| 2012-11-30 | -772.73% |
| 2012-08-31 | -610.22% |
| 2012-05-31 | -185.98% |
| 2012-02-29 | -140.50% |
| 2011-11-30 | -187.00% |
| 2011-08-31 | -154.33% |
| 2011-05-31 | -109.82% |
| 2011-02-28 | -79.82% |
